Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript

Click to increase image sizeClick to decrease image size

Acknowledgments

The authors wish to thank Associazione Italiana per la Ricerca sul Cancro (AIRC) 5 × 1000, Milan, Italy (Special Program Metastases Special Program, No 21198) (to RF); Finanziamento Medi Progetti Universitari 2015 (Sapienza University of Rome) (to SC), Bandi di Ateneo per la Ricerca (Sapienza University of Rome, RM11816436B712AF) to SC and PRIN 2017 (2017PPS2XA_002) to SC.

Author contributions

FF wrote the manuscript; GC performed the molecular analysis at disease onset and during follow-up; GF, MM, IDS performed the molecular analysis under the supervision of SC and AG; MSDP performed the immunophenotypic analysis at diagnosis and during the follow-up; FM and IDG made the morphological diagnosis; WB, SM followed the clinical course of patient during chemotherapy and stem cell transplant; RF and AMT reviewed the final manuscript and made therapeutic decision about the patient.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This paper was also supported by grant from AIRC to GC, and by funding of the association “Comitato Maria Letizia Verga” for “Passaporto Genetico” project [to GC and GF].